Replies to post #518642 on NorthWest Biotherapeutics Inc (NWBO)

[hoffmann6383]

No, it is actually 2022. The year NWBO got PIP approval. The year NWBO is likely to get commercial manufacturing certification. The year NWBO is likely to submit their MAA (and maybe BLA).

Have a great one Jammy!

[scotty3371]

I think the market now wants revenues, not just approvals.

Shares might jump if market is expecting 3 million in 2023 q4 revenue and its 5 million.

Tough to say. There is no denying shares are 70 cents!!!

[LearningEveryTrade]

LOW. LOL. This is not an elite pharmaceutical company, it is a clinical stage biotech. Things take time, yes, we have surpassed the 15 year average for a new drug to be developed. Rest assured, market cap is keeping up with dilution just fine, so the 70 cents might be deceiving.